Usmani, Saad Zafar; Schjesvold, Fredrik Hellem; Oriol, Albert; Karlin, Lionel; Cavo, Michele; Rifkin, Robert M.; Yimer, Habte Aragaw; LeBlanc, Richard; Takezako, Naoki; McCroskey, Robert Donald; Lim, Andrew Boon Ming; Suzuki, Kenshi; Kosugi, Hiroshi; Grigoriadis, George; Avivi, Irit; Facon, Thierry; Jagannath, Sundar; Lonial, Sagar; Ghori, Razi Uddin; Farooqui, Mohammed Z.H.; Marinello, Patricia; San-Miguel, Jesús (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2019)
Background
Lenalidomide and dexamethasone has been a standard of care in transplant-ineligible patients with newly diagnosed multiple myeloma. The addition of a third drug to the combination is likely to improve treatment ...